Who owns Karyopharm Therapeutics?
- Ticker: KPTI
- CUSIP Number: 48576u106
Tip: Access positions for across all investors
Analyze quarterly positions in Karyopharm Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Karyopharm Therapeutics stock
Who bought or sold Karyopharm Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 7.7M | $6.4M | 0% | Sep 2024 |
|
| Eversept Partners | 5.5M | $4.6M | 11% | Sep 2024 |
|
| Palo Alto Investors | 5.1M | $4.2M | 0% | Sep 2024 |
|
| Adage Capital Partners GP | 4.3M | $3.6M | 0% | Sep 2024 |
|
| BlackRock | 3.6M | $3.0M | 100% | Sep 2024 |
|
| Citadel Advisors | 3.2M | $2.7M | 0% | Sep 2024 |
|
| Marshall Wace | 2.1M | $1.7M | -19% | Sep 2024 |
|
| Avidity Partners Management | 2.0M | $1.7M | 0% | Sep 2024 |
|
| Bnp Paribas Arbitrage, Snc | 2.0M | $1.6M | -13% | Sep 2024 |
|
| GSA Capital Partners | 1.8M | $1.5M | 81% | Sep 2024 |
|
| CAM Group Holding A/S | 1.5M | $1.2M | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 1.4M | $1.2M | 9% | Sep 2024 |
|
| Geode Capital Management | 1.4M | $1.1M | 3% | Sep 2024 |
|
| Goldman Sachs Group | 1.3M | $1.1M | -42% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 1.3M | $1.1M | 0% | Sep 2024 |
|
| Millennium Management | 1.3M | $1.0M | -40% | Sep 2024 |
|
| Renaissance Technologies | 1.2M | $1.0M | 64% | Sep 2024 |
|
| Kennedy Capital Management | 1.2M | $999k | 1% | Sep 2024 |
|
| UBS O'Connor | 1.2M | $993k | 100% | Sep 2024 |
|
| D. E. Shaw & Co | 1.0M | $869k | 24% | Sep 2024 |
|
| Altium Capital Management | 740k | $614k | 0% | Sep 2024 |
|
| Silverarc Capital Management | 559k | $464k | 0% | Sep 2024 |
|
| Susquehanna International | 517k | $429k | -31% | Sep 2024 |
|
| Macquarie Group | 500k | $415k | -1% | Sep 2024 |
|
| Cubist Systematic Strategies | 496k | $412k | -13% | Sep 2024 |
|
| Birchview Capital | 470k | $390k | 0% | Sep 2024 |
|
| State Street Corporation | 410k | $340k | -10% | Sep 2024 |
|
| Ikarian Capital | 409k | $340k | 0% | Sep 2024 |
|
| FMR | 370k | $307k | 26% | Sep 2024 |
|
| Acadian Asset Management | 369k | $304k | 90% | Sep 2024 |
|
| Atom Investors | 260k | $216k | -1% | Sep 2024 |
|
| Bridgeway Capital Management | 240k | $199k | -9% | Sep 2024 |
|
| Northern Trust | 230k | $191k | 100% | Sep 2024 |
|
| Bank of America Corporation | 229k | $190k | -23% | Sep 2024 |
|
| Exchange Traded Concepts | 219k | $148k | 0% | Dec 2024 |
|
| Jane Street | 205k | $170k | -87% | Sep 2024 |
|
| DAFNA Capital Management | 193k | $160k | 0% | Sep 2024 |
|
| Bank of New York Mellon | 166k | $138k | 0% | Sep 2024 |
|
| T. Rowe Price Associates | 135k | $112k | 39% | Sep 2024 |
|
| UBS Group | 135k | $112k | -4% | Sep 2024 |
|
| Woodline Partners | 134k | $111k | 0% | Sep 2024 |
|
| Monashee Investment Management | 132k | $26k | 100% | Sep 2024 |
|
| Citigroup | 106k | $88k | -35% | Sep 2024 |
|
| Barclays | 96k | $79k | -89% | Sep 2024 |
|
| Boothbay Fund Management | 91k | $76k | 0% | Sep 2024 |
|
| Two Sigma Investments | 86k | $71k | 520% | Sep 2024 |
|
| Point72 Asia | 82k | $68k | -50% | Sep 2024 |
|
| Prudential Financial | 75k | $62k | 100% | Sep 2024 |
|
| Qube Research & Technologies | 62k | $52k | -42% | Sep 2024 |
|
| Invesco | 58k | $48k | 44% | Sep 2024 |
|
| HPM Partners | 52k | $43k | 100% | Sep 2024 |
|
| Charles Schwab Investment Management | 51k | $42k | 0% | Sep 2024 |
|
| Engineers Gate Manager | 48k | $40k | 68% | Sep 2024 |
|
| Hsbc Holdings | 40k | $31k | -24% | Sep 2024 |
|
| Baird Financial | 38k | $31k | 3% | Sep 2024 |
|
| Eqis Capital Management | 37k | $31k | -3% | Sep 2024 |
|
| Kennedy Investment Group | 35k | $24k | 0% | Dec 2024 |
|
| Two Sigma Advisers | 31k | $26k | 100% | Sep 2024 |
|
| Wolverine Trading | 28k | $20k | 13% | Sep 2024 |
|
| XTX Topco | 26k | $22k | -82% | Sep 2024 |
|
| Commonwealth Equity Services | 22k | $18k | -12% | Sep 2024 |
|
| CI Private Wealth | 21k | $18k | 55% | Sep 2024 |
|
| JustInvest | 17k | $14k | 100% | Sep 2024 |
|
| ELCO Management | 16k | $13k | -18% | Sep 2024 |
|
| Winthrop Advisory Group | 15k | $10k | 0% | Dec 2024 |
|
| Victory Capital Management | 15k | $12k | 4% | Sep 2024 |
|
| AQR Capital Management | 12k | $10k | -98% | Sep 2024 |
|
| Caprock | 12k | $7.8k | 100% | Dec 2024 |
|
| Gts Securities | 11k | $9.2k | -40% | Sep 2024 |
|
| Snowden Capital Advisors | 11k | $9.1k | 0% | Sep 2024 |
|
| BLB^B Advisors | 10k | $6.9k | 0% | Dec 2024 |
|
| Janney Montgomery Scott | 10k | $7.0k | 0% | Dec 2024 |
|
| Royal Bank of Canada | 8.0k | $6.4k | -86% | Sep 2024 |
|
| Advisor Group Holdings | 4.4k | $3.6k | 100% | Sep 2024 |
|
| Quent Capital | 3.5k | $2.4k | 0% | Dec 2024 |
|
| Pnc Financial Services | 3.0k | $2.5k | 0% | Sep 2024 |
|
| Lazard Asset Management | 1.6k | $999.933000 | 100% | Sep 2024 |
|
| Harbour Investments | 1.3k | $1.1k | 0% | Sep 2024 |
|
| Activest Wealth Management | 1.0k | $676.000000 | 0% | Dec 2024 |
|
| Wells Fargo & Company | 666.00 | $552.979800 | 4657% | Sep 2024 |
|
| SRS Capital Advisors | 538.00 | $447.024200 | 0% | Sep 2024 |
|
| Hanson McClain Advisors | 500.00 | $334.000000 | 0% | Dec 2024 |
|
| Bruce G. Allen Investments | 338.00 | $228.995000 | 0% | Dec 2024 |
|
| Atlantic Trust | 50.00 | $42.000000 | 0% | Sep 2024 |
|
| West Branch Capital | 48.00 | $33.000000 | 0% | Dec 2024 |
|
Who sold out of Karyopharm Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Opaleye Management | Jun 2024 | 1.4M | $1.2M |
| AlphaCentric Advisors | Sep 2024 | 1.1M | $934k |
| Superstring Capital Management | Jun 2024 | 535k | $464k |
| Y-Intercept | Jun 2024 | 411k | $357k |
| Thomas Stevens, CFA" | Jun 2024 | 354k | $307k |
| Centiva Capital | Jun 2024 | 204k | $177k |
| Hrt Financial | Jun 2024 | 148k | $128k |
| Alyeska Investment Group | Jun 2024 | 145k | $125k |
| State of Wyoming | Jun 2024 | 83k | $72k |
| Verition Fund Management | Jun 2024 | 69k | $60k |
| Schonfeld Strategic Advisors | Jun 2024 | 58k | $50k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 57k | $49k |
| Simplicity Wealth | Jun 2024 | 49k | $43k |
| Colony | Jun 2024 | 46k | $44k |
| Point72 | Jun 2024 | 36k | $31k |
| Tower Research Capital | Jun 2024 | 35k | $31k |
| Jump Financial | Jun 2024 | 27k | $23k |
| Banque Cantonale Vaudoise | Jun 2024 | 25k | $22k |
| Neuberger Berman Group | Jun 2024 | 23k | $20k |
| Balyasny Asset Management | Jun 2024 | 23k | $20k |
| O'shaughnessy Asset Management | Jun 2024 | 22k | $19k |
| Sunrise Partners Limited Partnership | Jun 2024 | 15k | $13k |
| ProShare Advisors | Jun 2024 | 15k | $13k |
| Scientech Research | Jun 2024 | 11k | $9.5k |
| Streettalk Advisors | Sep 2024 | 10k | $8.4k |
| CWM | Jun 2024 | 6.2k | $5.0k |
| Founders Capital Management | Sep 2024 | 2.0k | $1.7k |
| Golden State Equity Partners | Sep 2024 | 1.8k | $1.5k |
| Providence Capital Advisors | Jun 2024 | 312.00 | $271.003200 |
| AdvisorNet Financial | Sep 2024 | 200.00 | $166.000000 |